The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 286.00
Bid: 286.50
Ask: 291.00
Change: 22.50 (8.54%)
Spread: 4.50 (1.571%)
Open: 262.00
High: 295.00
Low: 262.00
Prev. Close: 263.50
SYNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Perstorp Belgium

6 Mar 2017 07:02

RNS Number : 5461Y
Synthomer PLC
06 March 2017
 

The Company considers this announcement to contain inside information

 

6 March 2017

Synthomer plc

Acquisition of Perstorp Oxo Belgium AB

 

Synthomer plc (LSE:SYNT) ('Synthomer' or the 'Group'), a leading speciality chemicals company, today announces the acquisition of Perstorp Oxo Belgium AB ('Perstorp Belgium') from The Perstorp Group, a speciality chemicals innovator and supplier based in Sweden.

 

Synthomer will pay an enterprise value of €78 million which will be fully funded from existing financial resources. The acquisition, which completed on 5 March, represents a multiple of 8.5x 2016 Adjusted EBITDA(1). This is expected to fall to approximately 7.0x EBITDA post integration reflecting operational efficiencies and increased volumes to existing customers. Perstorp Belgium will be consolidated into Synthomer's results from March 2017.

 

In the year to 31 December 2016, Perstorp Belgium generated reported earnings before interest and tax of €8 million. At 31 December 2016, Perstorp Belgium had gross assets of €21 million.

 

Perstorp Belgium is a niche performance additives business serving the decorative and industrial coatings industries. It has strong market leadership positions (#1 or #2) and serves a highly attractive, blue-chip customer base. The business operates from a well located, single site in Ghent, Belgium where there is potential for growth capacity for future demand.

 

Perstorp Belgium is highly complementary to Synthomer's existing markets and customers. The Group will focus on expanding Perstorp Belgium's market position by developing closer relationships with customers through leveraging its existing sales and technical services infrastructure, and driving operational performance.

 

Calum MacLean, Chief Executive Officer of Synthomer, commented:

"The acquisition of Perstorp Belgium represents another step forward in our strategy to continue to grow and develop Synthomer. The business is an excellent fit and provides increased access to new products and customers. We look forward to welcoming our new colleagues and integrating the business with Synthomer through the remainder of this year."

 

Note 1 - Reported EBITDA of €8.8m excluding certain Perstorp Group overhead cost allocations of €0.3m resulting in Adjusted EBITDA of €9.1m

 

-Ends-

Enquiries:

Calum MacLean, Chief Executive Officer

Tel: 01279 436211

Stephen Bennett, Chief Financial Officer

Tel: 01279 436211

Charles Armitstead, Teneo Blue Rubicon

Tel: 020 3603 5220

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQLLFIDVRIEIID
Date   Source Headline
9th May 201612:31 pmRNSDirector/PDMR Shareholding
28th Apr 20163:11 pmRNSResult of AGM
28th Apr 20167:00 amRNSQ1 Trading update
21st Apr 20161:44 pmRNSHolding(s) in Company
20th Apr 20162:23 pmRNSDirector Declaration
11th Apr 20163:01 pmRNSDirector/PDMR Shareholding
11th Apr 20163:00 pmRNSDirector/PDMR Shareholding
31st Mar 20162:15 pmRNSAnnual Financial Report
21st Mar 20167:00 amRNSDisposal
21st Mar 20167:00 amRNSAcquisition
15th Mar 201612:29 pmRNSHolding(s) in Company
2nd Mar 20167:00 amRNSPreliminary Results for the year ended 31 Dec 2015
10th Feb 20167:00 amRNSFRS 101 Notification
5th Feb 20163:34 pmRNSHolding(s) in Company
5th Feb 20163:13 pmRNSHolding(s) in Company
30th Nov 20153:00 pmRNSHolding(s) in Company
18th Nov 201510:30 amRNSDirector/PDMR Shareholding
6th Nov 20157:00 amRNSQ3 Trading Update
1st Oct 201512:50 pmRNSHolding(s) in Company
13th Aug 201510:05 amRNSHolding(s) in Company
11th Aug 20157:00 amRNSHalf Yearly Results
10th Jul 20152:43 pmRNSDirector/PDMR Shareholding
9th Jul 20159:12 amRNSHolding(s) in Company
7th Jul 20154:21 pmRNSHolding(s) in Company
6th Jul 20153:59 pmRNSHolding(s) in Company
2nd Jul 20157:00 amRNSTrading Update
22nd Jun 20153:51 pmRNSHolding(s) in Company
20th May 20158:57 amRNSHolding(s) in Company
14th May 201510:02 amRNSDirector/PDMR Shareholding
30th Apr 201512:53 pmRNSResult of AGM
30th Apr 201512:46 pmRNSDirectorate Change
30th Apr 20157:00 amRNSQuarter 1 Trading Update
27th Apr 201510:36 amRNSDirectorate Change
21st Apr 20155:16 pmRNSHolding(s) in Company
1st Apr 20158:15 amRNSDirectorate Change
31st Mar 20159:25 amRNSAnnual Financial Report
30th Mar 201510:13 amRNSHolding(s) in Company
27th Mar 201512:53 pmRNSDirector/PDMR Shareholding
23rd Mar 20157:00 amRNSDirectorate Change
19th Mar 201511:53 amRNSDirector Declaration
18th Mar 20154:47 pmRNSDirector/PDMR Shareholding
13th Mar 20159:35 amRNSHolding(s) in Company
27th Feb 20153:06 pmRNSDirector/PDMR Shareholding
27th Feb 20153:05 pmRNSDirector/PDMR Shareholding
26th Feb 20157:01 amRNSFinal Results
20th Jan 20151:58 pmRNSNotice of Results
16th Jan 20157:00 amRNSTrading update
18th Dec 20147:00 amRNSBoard Changes
18th Nov 20147:00 amRNSAppointment of Group Chief Executive
28th Oct 20147:00 amRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.